{
    "clinical_study": {
        "@rank": "62184", 
        "acronym": "RESPONSE 2", 
        "arm_group": [
            {
                "arm_group_label": "Ruxolitinib", 
                "arm_group_type": "Experimental", 
                "description": "52 patients- at a starting dose of 10 mg bid. Dose may be adjusted based on efficacy and safety parameters up to a maximum dose of 25 mg bid."
            }, 
            {
                "arm_group_label": "Best Available Therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "52 patients - as selected by the investigator from: Hydroxyurea, IFN/PEG-IFN, popobroman, anagrelide, IMIDs, or observation"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial will compare the efficacy and safety of ruxolitinib to Best Available Therapy\n      (BAT) in patients with polycythemia vera (PV) who are hyroxyurea (HU) resistant or\n      intolerant and do not have a palpable spleen."
        }, 
        "brief_title": "Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Polycythemia Vera", 
        "condition_browse": {
            "mesh_term": [
                "Polycythemia", 
                "Polycythemia Vera"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Confirmed diagnosis of PV according to the 2008 World Health Organization criteria,\n             Non-palpable spleen, Phlebotomy dependent, Resistant to or intolerant of hydroxyurea,\n             ECOG performance status of 0, 1 or 2.\n\n        Exclusion Criteria:\n\n          -  Inadequate liver or renal function, Significant bacterial, fungal, parasitic, or\n             viral infection requiring treatment, Active malignancy within the past 5 years,\n             excluding specific skin cancers, Previously received treatment with a JAK inhibitor,\n             Being treated with any investigational agent, Women who are pregnant or nursing.\n             Other inclusion/exclusion criteria apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "104", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02038036", 
            "org_study_id": "CINC424B2401"
        }, 
        "intervention": [
            {
                "arm_group_label": "Best Available Therapy", 
                "description": "Best Available Therapy as selected by the investigator from the below: 1. Hydroxyurea 2. IFN/PEG-IFN 3. Pipobroman 4. Anagrelide 5. IMIDs 6. Observation only", 
                "intervention_name": "Best Available Therapy", 
                "intervention_type": "Drug", 
                "other_name": "BAT"
            }, 
            {
                "arm_group_label": "Ruxolitinib", 
                "description": "Supplied as tablets. Starting dose of 10 mg bid. Based on efficacy and safety parameters, dose may be increased or decreased. Maximum dose allowed is 25mg bid.", 
                "intervention_name": "ruxolitinib", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hydroxyurea"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Polycythemia Vera", 
            "Hematologic Diseases", 
            "Myeloproliferative Disorders", 
            "Bone Marrow Diseases", 
            "Hydroxyurea", 
            "INC424", 
            "Ruxolitinib"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Herston", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4029"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium", 
                        "zip": "2060"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brugge", 
                        "country": "Belgium", 
                        "zip": "8000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bruxelles", 
                        "country": "Belgium", 
                        "zip": "1200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Chesnay", 
                        "country": "France", 
                        "zip": "78157"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille cedex", 
                        "country": "France", 
                        "zip": "59020"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg cedex", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse cedex 9", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "state": "Baden-W\u00fcrttemberg", 
                        "zip": "68305"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "01307"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "07740"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "zip": "04103"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minden", 
                        "country": "Germany", 
                        "zip": "32429"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89081"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "H-1083"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1097"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debrecen", 
                        "country": "Hungary", 
                        "zip": "4032"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaposvar", 
                        "country": "Hungary", 
                        "zip": "7400"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kecskemet", 
                        "country": "Hungary", 
                        "zip": "6000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyderabad", 
                        "country": "India", 
                        "state": "Andhra Pradesh", 
                        "zip": "500 096"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Delhi", 
                        "country": "India", 
                        "state": "Delhi", 
                        "zip": "110 060"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mumbai", 
                        "country": "India", 
                        "state": "Maharashtra", 
                        "zip": "400012"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vellore", 
                        "country": "India", 
                        "state": "Tamil Nadu", 
                        "zip": "632 004"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kolkata", 
                        "country": "India", 
                        "state": "West Bengal", 
                        "zip": "700 054"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Delhi", 
                        "country": "India", 
                        "zip": "110 029"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel", 
                        "zip": "91120"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nahariya", 
                        "country": "Israel", 
                        "zip": "22100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Netanya", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel-Aviv", 
                        "country": "Israel", 
                        "zip": "64239"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bergamo", 
                        "country": "Italy", 
                        "state": "BG", 
                        "zip": "24128"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "state": "BO", 
                        "zip": "40138"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "state": "FI", 
                        "zip": "50134"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20122"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20162"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "state": "PV", 
                        "zip": "27100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reggio Calabria", 
                        "country": "Italy", 
                        "state": "RC", 
                        "zip": "89124"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "RM", 
                        "zip": "00168"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "state": "TO", 
                        "zip": "10126"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "state": "VA", 
                        "zip": "21100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "state": "Korea", 
                        "zip": "135-710"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "state": "Korea", 
                        "zip": "120-752"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "state": "Andalucia", 
                        "zip": "29010"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salamanca", 
                        "country": "Spain", 
                        "state": "Castilla y Leon", 
                        "zip": "37007"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalunya", 
                        "zip": "08003"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain", 
                        "state": "Comunidad Valenciana", 
                        "zip": "03010"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Coruna", 
                        "country": "Spain", 
                        "state": "Galicia", 
                        "zip": "15006"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Palmas de Gran Canaria", 
                        "country": "Spain", 
                        "state": "Las Palmas de G.C", 
                        "zip": "35010"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra", 
                        "zip": "31008"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarau", 
                        "country": "Switzerland", 
                        "state": "CH", 
                        "zip": "5001"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Z\u00fcrich", 
                        "country": "Switzerland", 
                        "zip": "8091"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey", 
                        "zip": "34303"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey", 
                        "zip": "35040"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Talas / Kayseri", 
                        "country": "Turkey", 
                        "zip": "38039"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Australia", 
                "Belgium", 
                "Canada", 
                "France", 
                "Germany", 
                "Hungary", 
                "India", 
                "Israel", 
                "Italy", 
                "Korea, Republic of", 
                "Spain", 
                "Switzerland", 
                "Turkey"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Open Label, Multicenter Phase IIIb Study Evaluating the Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant (Response 2)", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+41613241111"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of patients achieving Hct control at Week 28 as defined by: \u2022Hct < 45% at Week 16 and maintained until Week 28, and \u2022No phlebotomy from Week 4 to Week 28, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit.", 
            "measure": "Efficacy of ruxolitinib to Best Available Therapy (BAT) as assessed by Hct control at Week 28", 
            "safety_issue": "No", 
            "time_frame": "Week 28"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02038036"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Proportion of patients achieving a peripheral blood count remission at Week 28 as defined by: Hct < 45% at Week 16 and maintained until Week 28, and WBC < 10 x10E9/L at Week 16 and maintained until Week 28, and Platelets \u2264 400 x 10E9/L at Week 16 and maintained until Week 28, and No phlebotomy from Week 4 to Week 28, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit.", 
                "measure": "Efficacy of ruxolitinib to BAT as assessed by peripheral blood count remission at Week 28.", 
                "safety_issue": "No", 
                "time_frame": "Week 28"
            }, 
            {
                "description": "Proportion of patients achieving a Hct control at Week 52 as defined by: Hct < 45% at Week 16 and maintained until Week 52, and no phlebotomy from Week 4 to Week 28, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit, and, in the BAT arm, no change in the treatment regimen or crossover to the ruxolitinib arm.", 
                "measure": "Efficacy of ruxolitinib to BAT as assessed by durable Hct control at Week 52", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }, 
            {
                "description": "Proportion of patients achieving a peripheral blood count remission at Week 52 as defined by: \u2022Hct < 45% at Week 16 and maintained until Week 52, and WBC < 10 x10E9/L at Week 16 and maintained until Week 52, and Platelets \u2264 400 x 10E9/L at Week 16 and maintained until Week 52, and, no phlebotomy from Week 4 to Week 52, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit, and in the BAT arm, no change in the treatment regimen or crossover to the ruxolitinib arm.", 
                "measure": "Efficacy of ruxolitinib to BAT as assessed by durable peripheral blood count remission at Week 52.", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }, 
            {
                "description": "Change in ECOG status from baseline to Week 28", 
                "measure": "Change in ECOG status", 
                "safety_issue": "No", 
                "time_frame": "Week 28"
            }, 
            {
                "description": "Change from Baseline in spleen length at each scheduled visit", 
                "measure": "Change in spleen length", 
                "safety_issue": "No", 
                "time_frame": "Week 4, 8, 12, 16, 20, 24, 28, 40, 52/End of Treatment"
            }, 
            {
                "description": "Proportion of patients achieving a partial remission at Week 28, based on the ELN and IWG-MRT criteria, as defined by: \u2022MPN-SAF TSS score reduction of greater than or equal to 10 points from baseline to Week 16 and maintained until Week 28 (for patients with a baseline score of 20 or more), and \u2022Hct < 45% at Week 16 and maintained until Week 28, and \u2022No phlebotomy from Week 4 to Week 28, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit, and \u2022WBC < 10 x10E9/L at Week 16 and maintained until Week 28, and \u2022Platelets \u2264 400 x 10E9/L at Week 16 and maintained until Week 28, and \u2022No palpable spleen at Week 16 and maintained until Week 28, and \u2022No hemorrhagic or thrombotic events, and \u2022No transformation into post-PV myelofibrosis, myelodysplastic syndrome, or acute leukemia", 
                "measure": "Efficacy of ruxolitinib to BAT as assessed by partial remission based on the ELN and IWG-MRT criteria at Week 28", 
                "safety_issue": "No", 
                "time_frame": "Week 28"
            }, 
            {
                "description": "Proportion of patients who achieved partial remission at Week 52, based on the ELN and IWG-MRT criteria, as defined by: \u2022MPN-SAF TSS score reduction of greater than or equal to 10 points from baseline to Week 16 and maintained until Week 52 (for patients with a baseline score of 20 or more), and \u2022Hct < 45% at Week 16 and maintained until Week 52, and \u2022No phlebotomy from Week 4 to Week 52, with no more than one phlebotomy occurring post randomization and prior to the Week 4 visit, and \u2022WBC < 10 x10E9/L at Week 16 and maintained until Week 52, and \u2022Platelets \u2264 400 x 10E9/L at Week 16 and maintained until Week 52, and \u2022No palpable spleen at Week 16 and maintained until Week 52, and \u2022No hemorrhagic or thrombotic events, and \u2022No transformation into post-PV myelofibrosis, myelodysplastic syndrome (IWG-MRT criteria) or acute leukemia (WHO criteria), and \u2022In the BAT arm, no change in the treatment regimen or crossover to the ruxolitinib arm.", 
                "measure": "Efficacy of ruxolitinib to BAT as assessed by durable partial remission based on the ELN and IWG-MRT criteria at Week 52.", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }, 
            {
                "description": "Among patients randomized to BAT who cross over to ruxolitinib, proportion of patients achieving Hct < 45% at each visit after cross over", 
                "measure": "Efficacy of BAT patients after they cross over to ruxolitinib", 
                "safety_issue": "No", 
                "time_frame": "+4, +8, +12, +16, +20, +24 weeks after crossover"
            }, 
            {
                "description": "Proportion of patients achieving at least a 50% reduction from baseline in MPN-SAF TSS score at each visit where it is measured.", 
                "measure": "Changes in MPN-SAF TSS", 
                "safety_issue": "No", 
                "time_frame": "Week 4, 8, 16, 28, 40, 52/End of Treatment"
            }, 
            {
                "description": "Proportion of patients achieving a resolution of disease related symptoms in MPN-SAF TSS at Week 28 defined as: \u2022 MPN-SAF TSS score reduction of greater than or equal to 10 points from baseline to Week 16 and maintained until Week 28 (for patients with a baseline score of 20 or more).", 
                "measure": "Resolution of disease related symptoms in MPN-SAF TSS at Week 28.", 
                "safety_issue": "No", 
                "time_frame": "Week 28"
            }, 
            {
                "description": "Change in MPN-SAF TSS from baseline to each visit where measured.\nPSIS at each visit where measured.\nChange in EQ-5D-5L score from baseline to each visit where measured.\nChange in WPAI from baseline to each visit where measured.\nPGIC at each visit where measured.", 
                "measure": "Changes in patient reported outcomes", 
                "safety_issue": "No", 
                "time_frame": "Week 4, 8, 16, 28, 40, 52/End of Treatment"
            }, 
            {
                "description": "Safety will be assessed by monitoring the frequency, duration and severity of Adverse Events, and evaluating changes in vital signs, electrocardiograms (ECGs), serum chemistry, hematology and urinalysis results.", 
                "measure": "Safety of ruxolitinib and Best Available Therapy", 
                "safety_issue": "Yes", 
                "time_frame": "Week 28, 52/EoT"
            }, 
            {
                "description": "Safety will be assessed by monitoring the frequency, duration and severity of Adverse Events, and evaluating changes in vital signs, electrocardiograms (ECGs), serum chemistry, hematology and urinalysis results.", 
                "measure": "Safety of BAT patients after they crossover", 
                "safety_issue": "Yes", 
                "time_frame": "+52/EoT"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}